CD in prevention of dengue-induced lethality
Annexin A1 (AnxA1) was identified as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac2-26, improved
A forum for researchers, students and applicants in the field of cyclodextrin technology
Annexin A1 (AnxA1) was identified as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac2-26, improved
In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral
The recent paper of Swiss and English researchers on modified cyclodextrins as antiviral agents received great attention in the bulvar.